In a filing, Neurocrine Biosciences, Inc revealed its Officer ERIC BENEVICH acquired Company’s shares for reported $0.9 million on Nov 28 ’25. In the deal valued at $151.58 per share,5,970 shares were bought.
Then, MORROW GEORGE J sold 15,000 shares, generating $2,150,512 in total proceeds. Upon selling the shares at $143.37, the Director now owns 7,068 shares.
Before that, GEORGE MORROW bought 15,000 shares. Neurocrine Biosciences, Inc shares valued at $2,118,750 were divested by the Director at a price of $141.25 per share.
Citigroup initiated its Neurocrine Biosciences, Inc [NBIX] rating to a Buy in a research note published on October 21, 2025; the price target was $175. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Goldman began covering NBIX with “Buy” recommendation on July 10, 2025. Needham revised its rating on April 15, 2025. It rated NBIX as “a Buy” which previously was an “a Hold”.
Price Performance Review of NBIX
On Monday, Neurocrine Biosciences, Inc [NASDAQ:NBIX] saw its stock fall -0.84% to $150.88. Over the last five days, the stock has gained 6.38%. Neurocrine Biosciences, Inc shares have risen nearly 17.96% since the year began. Nevertheless, the stocks have risen 10.53% over the past one year. While a 52-week high of $157.67 was reached on 11/05/25, a 52-week low of $84.23 was recorded on 04/09/25.
Levels Of Support And Resistance For NBIX Stock
The 24-hour chart illustrates a support level at 149.21, which if violated will result in even more drops to 147.54. On the upside, there is a resistance level at 152.92. A further resistance level may holdings at 154.96.
How much short interest is there in Neurocrine Biosciences, Inc?
A steep rise in short interest was recorded in Neurocrine Biosciences, Inc stocks on 2025-11-14, dropping by -1.01 million shares to a total of 3.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 4.37 million shares. There was a decline of -30.13%, which implies that there is a negative sentiment for the stock.
